Zobrazeno 1 - 10
of 22
pro vyhledávání: '"Seong-Kyun Na"'
Autor:
Yewan Park, Seong-Kyun Na, Jae-Hyun Yoon, Sung-Eun Kim, Ji-Won Park, Gi-Ae Kim, Hyo-Young Lee, Young-Sun Lee, Jeong-Han Kim
Publikováno v:
Medicina, Vol 60, Iss 7, p 1132 (2024)
Background and Objectives: Chronic hepatitis C (CHC) can be cured with direct-acting antiviral (DAA) therapy. In Korea, sofosbuvir (SOF) and ledipasvir (LDV)/SOF were launched in 2016. Patients who achieve a sustained virologic response (SVR) followi
Externí odkaz:
https://doaj.org/article/dc00c24c45bd4ff8a14399e11147bffb
Autor:
Chan Young Jeong, Gwang Hyeon Choi, Eun Sun Jang, Young Seok Kim, Youn-Jae Lee, In Hee Kim, Sung Bum Cho, Jae Hyun Yoon, Kyung-Ah Kim, Dae Hee Choi, Woo Jin Chung, Hyun Chin Cho, Seong Kyun Na, Yun-Tae Kim, Byung Seok Lee, Sook-Hyang Jeong
Publikováno v:
Scientific Reports, Vol 14, Iss 1, Pp 1-1 (2024)
Externí odkaz:
https://doaj.org/article/7c793e0a5e4941359e942fc688596865
Autor:
Chan Young Jeong, Gwang Hyeon Choi, Eun Sun Jang, Young Seok Kim, Youn-Jae Lee, In Hee Kim, Sung Bum Cho, Jae Hyun Yoon, Kyung-Ah Kim, Dae Hee Choi, Woo Jin Chung, Hyun Chin Cho, Seong Kyun Na, Yun-Tae Kim, Byung Seok Lee, Sook-Hyang Jeong
Publikováno v:
Scientific Reports, Vol 13, Iss 1, Pp 1-10 (2023)
Abstract This prospective, 12-center study investigated the etiology and clinical characteristics of acute viral hepatitis (AVH) during 2020–2021 in South Korea, and the performance of different diagnostic methods for hepatitis E virus (HEV). We en
Externí odkaz:
https://doaj.org/article/fafa880fc5b24078b6f1ef3ae7d720e0
Autor:
Seong Kyun Na
Publikováno v:
Journal of Liver Cancer, Vol 22, Iss 2, Pp 178-182 (2022)
Fibrolamellar hepatocellular carcinoma (FLHCC) is a rare malignant hepatic cancer with characteristics that differ from those of typical hepatocellular carcinoma (HCC). Unlike conventional HCC, FLHCC is common in young patients without any underlying
Externí odkaz:
https://doaj.org/article/97000ead602e41ff88f6e8ca346259c5
Autor:
Seong Kyun Na, Byung-Cheol Song
Publikováno v:
Clinical and Molecular Hepatology, Vol 25, Iss 3, Pp 234-244 (2019)
Hepatitis C virus (HCV) infection is a major risk factor for liver cirrhosis and hepatocellular carcinoma (HCC), and is a leading cause of liver-related deaths worldwide. Recently available direct-acting antiviral agent is very safe and highly effect
Externí odkaz:
https://doaj.org/article/266083c5391e4590ae47675b125d63d6
Publikováno v:
Hepatobiliary & Pancreatic Diseases International.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::6697374408e30c6e48159118fc11d4f4
https://doi.org/10.1016/j.hbpd.2023.02.009
https://doi.org/10.1016/j.hbpd.2023.02.009
Autor:
Seong Kyun Na, Gwang Hyeon Choi, Han Chu Lee, Yong Moon Shin, Jihyun An, Danbi Lee, Ju Hyun Shim, Kang Mo Kim, Young-Suk Lim, Young-Hwa Chung, Yung Sang Lee
Publikováno v:
PLoS ONE, Vol 13, Iss 6, p e0198138 (2018)
BACKGROUND:Combined hepatocellular-cholangiocarcinoma (cHCC-CC) can present as a hypervascular or peripherally enhancing tumor in dynamic imaging. We evaluated the effect of transarterial chemoembolization (TACE) on prognosis according to post-operat
Externí odkaz:
https://doaj.org/article/11a573c1c3d9421c95d1e86507a11311
Autor:
Seul-Ki Han, Seong-Hee Kang, Moon-Young Kim, Seong-Kyun Na, Taehyung Kim, Minjong Lee, Baek-Gyu Jun, Tae-Suk Kim, Dae-Hee Choi, Ki-Tae Suk, Young-Don Kim, Gab-Jin Cheon, Hyung-Joon Yim, Dong-Joon Kim, Soon-Koo Baik
Publikováno v:
Journal of Clinical Medicine; Volume 11; Issue 23; Pages: 7221
Background/Aims: The management of hepatic hydrothorax (HH) remains a challenging clinical scenario with suboptimal options. We investigated the effect and safety of pigtail catheter drainage compared to intermittent thoracentesis. Methods: This mult
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e03a91a9c2e094503c120be0483c1130
Publikováno v:
Journal of interferoncytokine research : the official journal of the International Society for Interferon and Cytokine Research. 39(11)
The risk of hepatocellular carcinoma (HCC) is not completely eliminated in chronic hepatitis C (CHC) patients even after viral eradication. There are few studies in predicting the development of HCC using biomarker in CHC patients with sustained viro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::967737d0b8cc039eaabe3a0029428ae3
https://pubmed.ncbi.nlm.nih.gov/31216229
https://pubmed.ncbi.nlm.nih.gov/31216229
Publikováno v:
Journal of Liver Cancer. 16:118-122
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a9ffa33e70cc2dcf7f73e25c9712dafa
https://doi.org/10.17998/jlc.16.2.118
https://doi.org/10.17998/jlc.16.2.118